Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Collette

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
Bone|February 13, 2001
Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosisB Zegels, R Eastell, R G Russell, et al.
Journal of Chronic Diseases|January 1, 1984
The DOM project for the early detection of breast cancer, Utrecht, The NetherlandsF de Waard, H J Collette, J J Rombach, et al.
Osteoarthritis and Cartilage|September 13, 2005
One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progressionM A Deberg, A H Labasse, J Collette, et al.
Gynecologie, Obstetrique & Fertilite|October 22, 2003
[Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate]J Collette, P Viethel, M Dethor, et al.
Breast Cancer Research and Treatment|June 14, 2000
Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4A Hajitou, C Deroanne, A Noël, et al.
Annales De Pathologie|January 1, 1982
[Tumor markers]P Franchimont, P F Zangerle, J Collette, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 9, 2009
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 yearsO Bruyère, J Collette, R Rizzoli, et al.
Diabetes/Metabolism Research and Reviews|April 18, 2001
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetesO Kecha-Kamoun, I Achour, H Martens, et al.
Anticancer Research|September 1, 1986
Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humansC Focan, D Focan-Henrard, J Collette, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000V Le Doussal, P F Zangerle, J Collette, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Bone|February 13, 2001
Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosisB Zegels, R Eastell, R G Russell, et al.
Journal of Chronic Diseases|January 1, 1984
The DOM project for the early detection of breast cancer, Utrecht, The NetherlandsF de Waard, H J Collette, J J Rombach, et al.
Osteoarthritis and Cartilage|September 13, 2005
One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progressionM A Deberg, A H Labasse, J Collette, et al.
Gynecologie, Obstetrique & Fertilite|October 22, 2003
[Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate]J Collette, P Viethel, M Dethor, et al.
Breast Cancer Research and Treatment|June 14, 2000
Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4A Hajitou, C Deroanne, A Noël, et al.
Annales De Pathologie|January 1, 1982
[Tumor markers]P Franchimont, P F Zangerle, J Collette, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 9, 2009
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 yearsO Bruyère, J Collette, R Rizzoli, et al.
Diabetes/Metabolism Research and Reviews|April 18, 2001
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetesO Kecha-Kamoun, I Achour, H Martens, et al.
Anticancer Research|September 1, 1986
Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humansC Focan, D Focan-Henrard, J Collette, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000V Le Doussal, P F Zangerle, J Collette, et al.
Pageof 15